SEC Form 4 · accession 0001104659-17-017454
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 11:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2017 | P | 10,000 | $5.97 | A | 40,000 | D | |
| Common StockF1 | holding | — | — | — | 4,275 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.